FINNENCE ▪ THE WIRE FILE
THE WIRE · № 76376
News■ Unclear/unknown
Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2026 Financial Results
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Earnings scheduling notice; no drug sales or pipeline data disclosed.
Scheduling notice, nothing actionable
CATALYST TO WATCH
Q3 results November 2
MAIN RISK
Drug sales may miss expectations
FULL DISPATCH
Conference Call and Webcast Scheduled for Monday, November 2 SAN DIEGO, Oct. 12, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it has scheduled its third quarter 2026 financial results conference call and webcast for 1:30 p.m. Pacific Time (4:30 p.m....
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
New TREMFYA® (guselkumab) study shows consistent perianal fistula remission across key Crohn's disease patient subgroups2026-10-12 20:05 UTC
New TREMFYA® (guselkumab) study shows consistent perianal fistula remission across key Crohn's disease patient subgroups2026-10-12 20:05 UTC
→CORRELATIONshares Healthcare
TREMFYA® (guselkumab) demonstrated sustained clinical and endoscopic remission through 3 years in moderately to severely active Crohn's disease2026-10-12 20:05 UTC
TREMFYA® (guselkumab) demonstrated sustained clinical and endoscopic remission through 3 years in moderately to severely active Crohn's disease2026-10-12 20:05 UTC
→CORRELATIONshares Healthcare
Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care2026-10-12 20:25 UTC
Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care2026-10-12 20:25 UTC
→CORRELATIONshares Healthcare
ACG 2026 Data Show TissueCypher® Identifies Elevated Risk of Progression Beyond Pathology Findings in Barrett's Esophagus2026-10-12 20:30 UTC
ACG 2026 Data Show TissueCypher® Identifies Elevated Risk of Progression Beyond Pathology Findings in Barrett's Esophagus2026-10-12 20:30 UTC
←CORRELATIONshares Healthcare
National Survey of Healthcare Professionals Reveals Knowledge Gaps Around Indoor Air Quality and Offers Opportunities to Better Support At-Risk Patients2026-10-12 15:35 UTC
National Survey of Healthcare Professionals Reveals Knowledge Gaps Around Indoor Air Quality and Offers Opportunities to Better Support At-Risk Patients2026-10-12 15:35 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.